熱門資訊> 正文

Citius Pharmaceuticals重新获得纳斯达克合规

2025-07-08 20:48

Citius Pharmaceuticals (NASDAQ:CTXR) announced on Tuesday it received a Nasdaq notification, indicating that the company regained compliance with Nasdaq's minimum bid price requirement rule of $1.00 per share for continued listing.
The company said the previously scheduled Nasdaq Hearing Panel has been cancelled. Nasdaq informed the company that Citius Pharma's securities will continue to be listed and traded on Nasdaq.
CTXR +1.46% premarket to $2.1358.
Source: Press Release

More on Citius Pharmaceuticals

Citius Pharmaceuticals slides on $15.8M securities offering
Citius Oncology enters distribution services agreement with Cardinal Health
Seeking Alpha’s Quant Rating on Citius Pharmaceuticals
Historical earnings data for Citius Pharmaceuticals
Financial information for Citius Pharmaceuticals

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。